mSphere
(Feb 2021)
Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients
- Skye R. S. Fishbein,
- Tiffany Hink,
- Kimberly A. Reske,
- Candice Cass,
- Emily Struttmann,
- Zainab Hassan Iqbal,
- Sondra Seiler,
- Jennie H. Kwon,
- Carey-Ann D. Burnham,
- Gautam Dantas,
- Erik R. Dubberke
Affiliations
- Skye R. S. Fishbein
- ORCiD
- The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA
- Tiffany Hink
- Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
- Kimberly A. Reske
- Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
- Candice Cass
- Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
- Emily Struttmann
- Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
- Zainab Hassan Iqbal
- Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
- Sondra Seiler
- Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
- Jennie H. Kwon
- Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
- Carey-Ann D. Burnham
- ORCiD
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
- Gautam Dantas
- ORCiD
- The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA
- Erik R. Dubberke
- Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
- DOI
-
https://doi.org/10.1128/mSphere.00936-20
- Journal volume & issue
-
Vol. 6,
no. 1
Abstract
Read online
A gold standard diagnostic for Clostridioides difficile
WeChat QR code
